Notably, AD patients demonstrated markedly higher urinary CX3CL1 levels compared to both aMCI patients and CN subjects, while aMCI patients showed significantly lower levels than those observed in the AD and CN groups. Here, CX3CL1 is linked to Alzheimer disease.